Experimental drug citicoline shows promise after stroke
Researchers at 21 hospitals report citicoline reduces brain damage and speeds recovery when given up to 24 hours after stroke onset. The study, funded by Interneuron Pharmaceuticals, notes safety and broader potential though FDA approval pending. Dr Wayne Clark led the Oregon Health Sciences team presenting at the American Academy of Neurology meeting in San Francisco.
MENTIONED IN THIS ARTICLE
Agen
Sean Oe
Stroke Association
Wayne Clark
Amercan Academy of Neurology
San Francisco
Also Mentioned on This Page
Eee Oeen
Ananes
Interneuron Pharmaceuticals Inc
Lexington
Vibe
Eeee
The
Food and Drug Administration
Clark
Oregon Health Sciences Uni
Richard Wurtman
Massachusetts Institute of Technology
Goiberts
JO Ann
Southwestern Bell Mobile Systems
New Mexico
Oklahoma
Texas Panhandies
West Texas
L Worth
Odessa
Motorola
Flip Phone
Spek
Frontier Galleries
East 8Th Street
St. Augusta
Bios
Perma Growied
Ate
Soar
Planterray
Pouraco Products, Inc
Operi
Midland
W. Scharbauer
Andrew's Hwy